California-based Atropos Health has secured $33 million in Series B funding led by Valtruis. New investors include McKesson Ventures, Merck GHI Fund, and Cencora Ventures, with existing investors also participating. The company offers real-world data platform and AI innovations to assist physicians in making evidence-based clinical decisions. They will use the funds to expand into oncology and specialty care. Atropos has also partnered with companies like Datavant and Arcadia to provide access to additional healthcare data. CEO Dr. Brigham Hyde emphasizes the importance of evidence-based decisions in healthcare, especially in areas like oncology where the stakes are high.
Source link
Real-world data platform Atropos Health raises $33M
